Highland Capital Management, LLC Apellis Pharmaceuticals, Inc. Transaction History
Highland Capital Management, LLC
- $1.96 Billion
- Q3 2025
A detailed history of Highland Capital Management, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Highland Capital Management, LLC holds 50,133 shares of APLS stock, worth $1.03 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
50,133Holding current value
$1.03 Million% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding APLS
# of Institutions
304Shares Held
134MCall Options Held
2.97MPut Options Held
623K-
Avoro Capital Advisors LLC New York, NY12.2MShares$250 Million3.86% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$244 Million17.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$208 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.75MShares$200 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.98MShares$184 Million0.03% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.25B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...